Pharmacologic inhibition of protein phosphatase-2A achieves durable immune-mediated antitumor activity when combined with PD-1 blockade

被引：64

作者：

Ho, Winson S. ^{[1
]}

Wang, Herui ^{[2
]}

Maggio, Dominic ^{[1
]}

Kovach, John S. ^{[3
]}

Zhang, Qi ^{[2
]}

Song, Qi ^{[2
,4
]}

Marincola, Francesco M. ^{[5
]}

Heiss, John D. ^{[1
]}

Gilbert, Mark R. ^{[2
]}

Lu, Rongze ^{[5
,6
]}

Zhuang, Zhengping ^{[1
,2
]}

机构：

[1] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA

[2] NCI, Neurooncol Branch, NIH, Bethesda, MD 20892 USA

[3] Lixte Biotechnol Holdings Inc, East Setauket, NY 11733 USA

[4] Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China

[5] AbbVie Biotherapeut, Redwood City, CA 94063 USA

[6] MedImmune, Gaithersburg, MD 20878 USA

来源：

NATURE COMMUNICATIONS | 2018年 / 9卷

基金：

美国国家卫生研究院;

关键词：

T-CELL; OKADAIC ACID; CHECKPOINT BLOCKADE; SOLID TUMORS; IMMUNOTHERAPY TARGETS; UNTREATED MELANOMA; 2A INHIBITION; PHASE-I; CANCER; PP2A;

D O I：

10.1038/s41467-018-04425-z

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Mounting evidence suggests that inhibition of protein phosphatase-2A (PP2A), a serine/threonine phosphatase, could enhance anticancer immunity. However, drugs targeting PP2A are not currently available. Here, we report that a PP2A inhibitor, LB-100, when combined with anti-PD-1 (aPD-1) blockade can synergistically elicit a durable immune-mediated antitumor response in a murine CT26 colon cancer model. This effect is T-cell dependent, leading to regression of a significant proportion of tumors. Analysis of tumor lymphocytes demonstrates enhanced effector T-cell and reduced suppressive regulatory T-cell infiltration. Clearance of tumor establishes antigen-specific secondary protective immunity. A synergistic effect of LB-100 and aPD-1 blockade is also observed in B16 melanoma model. In addition, LB-100 activates the mTORC1 signaling pathway resulting in decreased differentiation of naive CD4 cells into regulatory T cells. There is also increased expression of Th1 and decreased expression of Th2 cytokines. These data highlight the translational potential of PP2A inhibition in combination with checkpoint inhibition.

引用

页数：15

共 41 条

[21] The Role and Therapeutic Potential of Ser/Thr Phosphatase PP2A in Apoptotic Signalling Networks in Human Cancer Cells [J].

Janssens, V. ;

Rebollo, A. .

CURRENT MOLECULAR MEDICINE, 2012, 12 (03) :268-287

[22] PP2A holoenzyme assembly:: in cauda venenum (the sting is in the tail) [J].

Janssens, Veerle ;

Longin, Sari ;

Goris, Jozef .

TRENDS IN BIOCHEMICAL SCIENCES, 2008, 33 (03) :113-121

[23] PP2A: The Wolf in Sheep's Clothing? [J].

Kiely, Maeve ;

Kiely, Patrick A. .

CANCERS, 2015, 7 (02) :648-669

[24] CANCER Live screening of immunotherapy targets [J].

Kingwell, Katie .

NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (04) :258-258

[25] DIRECT VISUALIZATION AND QUANTIFICATION OF CELLULAR CYTOTOXICITY USING 2 COLOR FLUORESCENCE [J].

KROESEN, BJ ;

MESANDER, G ;

TERHAAR, JG ;

THE, TH ;

DELEIJ, L .

JOURNAL OF IMMUNOLOGICAL METHODS, 1992, 156 (01) :47-54

[26] Rescue of GABAB and GIRK function in the lateral habenula by protein phosphatase 2A inhibition ameliorates depression-like phenotypes in mice [J].

Lecca, Salvatore ;

Pelosi, Assunta ;

Tchenio, Anna ;

Moutkine, Imane ;

Lujan, Rafael ;

Herve, Denis ;

Mameli, Manuel .

NATURE MEDICINE, 2016, 22 (03) :254-261

[27] PROTEIN PHOSPHATASE-2A AND ITS [H-3] CANTHARIDIN [H-3] ENDOTHALL THIOANHYDRIDE BINDING-SITE - INHIBITOR SPECIFICITY OF CANTHARIDIN AND ATP ANALOGS [J].

LI, YM ;

MACKINTOSH, C ;

CASIDA, JE .

BIOCHEMICAL PHARMACOLOGY, 1993, 46 (08) :1435-1443

[28] Inhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms [J].

Lu, Jie ;

Kovach, John S. ;

Johnson, Francis ;

Chiang, Jeffrey ;

Hodes, Richard ;

Lonser, Russell ;

Zhuang, Zhengping .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (28) :11697-11702

[29] T-Cell and NK-Cell Infiltration into Solid Tumors: A Key Limiting Factor for Efficacious Cancer Immunotherapy [J].

Melero, Ignacio ;

Rouzaut, Ana ;

Motz, Greg T. ;

Coukos, George .

CANCER DISCOVERY, 2014, 4 (05) :522-526

[30] CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms [J].

Parry, RV ;

Chemnitz, JM ;

Frauwirth, KA ;

Lanfranco, AR ;

Braunstein, I ;

Kobayashi, SV ;

Linsley, PS ;

Thompson, CB ;

Riley, JL .

MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (21) :9543-9553

← 1 2 3 4 5 →